Quarterly Institutional Activity in FWP

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding FWP

View all

Latest Institutional Activity in FWP

Top Purchases

Q3 2022
Perigon Wealth Management, LLC Shares Held: 18.1K ($46.4K)
Q3 2022
Ubs Group Ag Shares Held: 2.16K ($5.52K)
Q3 2022
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q2 2022
Bvf Inc Shares Held: 514K ($1.32M)

Top Sells

Q2 2023
Mason Capital Management LLC Shares Held: 525 ($1.34K)
Q3 2022
Morgan Stanley Shares Held: 163K ($418K)
Q2 2022
Renaissance Technologies LLC Shares Held: 14.5K ($37.1K)
Q2 2022
Citigroup Inc Shares Held: 0 ($0)
Q2 2022
Advisor Group Holdings, Inc. Shares Held: 1 ($2.56)

About FWP

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.


Insider Transactions at FWP

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on FWP

Follow Forward Pharma A/S and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FWP shares.

Notify only if

Insider Trading

Get notified when an Forward Pharma A/S insider buys or sells FWP shares.

Notify only if

News

Receive news related to Forward Pharma A/S

Track Activities on FWP